Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease
NCT01696708
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER_GOV
Sponsor class
Conditions
Huntington Disease
Interventions
OTHER:
31-Phosphorus RMN Spectroscopy
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France